Micro Therapeutics Receives Favorable FDA Audit Results
(PR Newswire)...the FDA granted MTI approval to begin a pivotal clinical trial of the company`s Onyx(TM) Liquid Embolic System (Onyx LES(TM)) to study the treatment of brain aneurysms.......MTI has already received CE Mark approval to commercialize Onyx for the treatment of aneurysms, AVMs, brain tumors and peripheral vascular conditions....- May 02 12:00 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010502/law065.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines